Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Ann Dermatol Venereol ; 123(12): 817-20, 1996.
Article in French | MEDLINE | ID: mdl-9636770

ABSTRACT

INTRODUCTION: Amineptine-induced acne is a classical side effect often encountered after prolonged and excessive use of the antidepressor. CASE REPORT: We report the case of a young female drug addict (benzodiazepines and alcohol) who denied overuse of amineptine. The initial inflammatory aspect of the lesion was unusual as was the histology report. The sebaceous glands were the site of cystic dilatation as would be expected, but in addition the sudoriparous glands showed keratinizing syringometaplasia with areas of neutrophilic eccrine hidradenitis. DISCUSSION: This is the second report of such a case similar to other due to chemotherapy, benaxoprofene or toxic agents for example, and corresponds to direct toxicity to the sudoriparous glands which accumulate amineptine. We therefore propose the term of adnexal toxic drug eruption.


Subject(s)
Acne Vulgaris/chemically induced , Antidepressive Agents, Tricyclic/adverse effects , Dibenzocycloheptenes/adverse effects , Drug Eruptions/etiology , Facial Dermatoses/chemically induced , Acne Vulgaris/pathology , Adult , Drug Eruptions/pathology , Facial Dermatoses/pathology , Female , Humans , Iatrogenic Disease
2.
Arch Dermatol ; 131(12): 1381-5, 1995 Dec.
Article in English | MEDLINE | ID: mdl-7492125

ABSTRACT

BACKGROUND AND DESIGN: We retrospectively studied 12 patients with dermatomyositis (DM) with at least one laboratory criterion of muscle involvement but without muscle weakness. We reported their outcome without systemic corticosteroid treatment and searched for distinctive baseline data and associated neoplasia among a group of 29 patients with classic DM. RESULTS: After a mean follow-up of 5.3 years, complete or partial skin improvement occurred in nine patients with DM without muscle weakness, and muscle enzyme levels were normalized in all. When compared with the classic DM group, no statistical differences were found for associated neoplasia or for any baseline data studied except, as expected, for muscle parameters. CONCLUSIONS: The lack of distinctive baseline data between DM without muscle weakness and classic DM suggests that there is a continuum from amyopathic to classic DM. However, DM without muscle weakness is a clinical entity with respect to favorable long-term prognosis. Unless frank muscle weakness develops, treatment with systemic corticosteroids can be avoided.


Subject(s)
Dermatomyositis/drug therapy , Adolescent , Adrenal Cortex Hormones , Adult , Aged , Antirheumatic Agents/therapeutic use , Case-Control Studies , Child , Dermatomyositis/enzymology , Dermatomyositis/pathology , Dermatomyositis/physiopathology , Female , Follow-Up Studies , Humans , Hydroxychloroquine/therapeutic use , Longitudinal Studies , Male , Middle Aged , Muscle Weakness/physiopathology , Muscle, Skeletal/enzymology , Muscle, Skeletal/physiopathology , Paraneoplastic Syndromes/pathology , Prognosis , Retrospective Studies , Skin/pathology , Treatment Outcome
3.
C R Acad Sci III ; 316(4): 437-40, 1993.
Article in English | MEDLINE | ID: mdl-8402273

ABSTRACT

Few abnormalities have been described up to know in the red cell lineage of HIV patients except for a slight anemia. To better interpret this, a hemoglobin study was performed in a group of 71 HIV infected patients. By contrast to patients at stage II or III, those at stage IV of the disease had moderate elevation of HbA2 level. A second group of ten patients being at stage IV of HIV infection and having moderate increase in HbA2 level were found to have beta thalassemia-like unbalanced biosynthetic globin ratio, unlike a control group with chronic inflammation condition. The observed abnormality may be a feature reflecting the peculiar disordered erythropoiesis seen in the late stage of this disease.


Subject(s)
HIV Infections/blood , Hemoglobins/biosynthesis , Adult , Female , HIV Infections/complications , HIV Infections/pathology , Hemoglobin A2/analysis , Humans , Male , Middle Aged , beta-Thalassemia/blood , beta-Thalassemia/etiology
4.
Ann Chir ; 46(7): 615-9, 1992.
Article in French | MEDLINE | ID: mdl-1456693

ABSTRACT

The aim of this study was to evaluate the pain relief related to resection of the celiac plexus in pancreatic carcinoma. This technique was attempted in 26 consecutive patients and performed in 23 (feasibility: 88%), whose mean age was 64 years. Before surgery, patients were divided into two groups: patients not treated by narcotic analgesics (group 1, n = 10) and patients treated by narcotic analgesics (group II, n = 13). Surgery was indicated in 22 patients for pancreatic resection or by-pass, and in 1 patient for pain relief after an unsuccessful per-cutaneous celiac plexus block. Resection of the celiac plexus was always performed via a trans-peritoneal approach, after mobilization of the head of the pancreas and the duodenum. Only the right half of the celiac plexus was resected in 4 patients (17%) due to technical difficulties. Pathologic examination was performed in 16 patients (8 patients from each group) and neoplastic involvement was observed only in 3 patients of group II. There was no operative death. Two complications related to this method occurred (9%). One patient developed a chylous ascites and was treated conservatively. In a second patient, an occlusion of the celiac trunk was complicated by infarction of the spleen and of the left lobe of the liver; this patient was reoperated and his subsequent post-operative course was uneventful. In group I, eight patients (80%) did not require narcotic analgesics after resection of the celiac plexus. Two failures occurred, one immediately after surgery and one delayed. In group II, seven patients (53%) did not require narcotic analgesics; 6 of these 7 patients died. Six failures occurred, 4 early after surgery and 2 delayed. Three of the 4 early failures occurred in patients who underwent resection of the right half of the celiac plexus. The authors concluded that resection of the celiac plexus seems to be an effective pain treatment in pancreatic carcinoma. However, resection must be bilateral to provide analgesia. Specific morbidity of this technique may lead to the use of non-surgical methods if surgery is not indicated for pancreatic resection or by-pass.


Subject(s)
Adenocarcinoma/surgery , Analgesia/methods , Celiac Plexus/surgery , Pain/prevention & control , Pancreatic Neoplasms/surgery , Adenocarcinoma/complications , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Pain/etiology , Pain, Postoperative , Pancreatic Neoplasms/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...